Woman staring out window

As a functional medicine clinician, it’s essential to understand the physiological and neurological foundations of Seasonal Affective Disorder (SAD) to better support patients during seasonal transitions. This article provides an overview of SAD and explores the critical role neurotransmitters, melatonin, and cortisol play in its manifestation. With this understanding, clinicians can implement targeted, evidence-based interventions.

Understanding Seasonal Affective Disorder (SAD)

SAD is a subtype of major depressive disorder characterized by its seasonal recurrence, typically presenting during fall and winter when daylight exposure decreases. Common symptoms include:

  • Persistent depressive mood or affect
  • Anhedonia (loss of interest in previously enjoyable activities)
  • Profound fatigue and reduced energy levels
  • Cognitive impairments, such as difficulty concentrating
  • Hypersomnia or altered sleep patterns
  • Cravings for high-carbohydrate foods and associated weight gain

SAD is more prevalent in regions with prolonged winters and limited sunlight exposure, disproportionately affecting women and younger adults.

Neurotransmitter Dysregulation in SAD

Research highlights the role of neurotransmitter imbalances in SAD, including:

  • Serotonin: Reduced serotonin activity, influenced by diminished sunlight exposure, correlates with depressive symptoms, emotional dysregulation, and carbohydrate cravings that often lead to weight gain.
  • Melatonin: Prolonged darkness during winter increases daytime melatonin secretion, disrupting circadian rhythms and contributing to hypersomnia and lethargy.
  • Dopamine: Impaired dopamine function may explain the reduced motivation and reward-seeking behaviors in SAD patients.

Diurnal Cortisol and Seasonal Affective Disorder

Disrupted diurnal cortisol patterns are frequently observed in SAD patients. These disruptions include:

  • Flattened Cortisol Curves: Reduced morning peaks and elevated evening levels exacerbate depressive symptoms, impair energy regulation, and contribute to sleep disturbances.
  • Cortisol Awakening Response (CAR): A blunted or delayed CAR reflects impaired HPA axis reactivity, contributing to fatigue, reduced stress resilience, and mood disturbances.

Support Strategies:

Evidence-based strategies include:

  1. Bright Light Therapy (BLT): Administer 10,000 lux for 20-30 minutes in the morning. BLT suppresses melatonin production and enhances serotonin activity, making it a first-line treatment for SAD.
  2. 5-HTP: This natural amino acid and serotonin precursor may help restore serotonin levels and alleviate depressive symptoms.
  3. Vitamin D Supplementation: Low vitamin D levels are common in SAD patients. Supplementation supports serotonin and dopamine pathways, improving mood.
  4. Cognitive Behavioral Therapy (CBT): CBT tailored for SAD (CBT-SAD) helps patients reframe maladaptive thoughts and behaviors.
  5. Lifestyle Interventions: Encourage regular movement, time outdoors for natural light exposure and grounding, and optimizing sleep hygiene. Walking, in particular, has been shown to elevate mood even when patients are initially unmotivated.
  6. Botanical Interventions:
    • St. John’s Wort (Hypericum perforatum): Known for its antidepressant properties, it may improve mood and reduce depressive symptoms.
    • Saffron (Crocus sativus): Studies suggest it may be as effective as conventional antidepressants for mild to moderate depression.
  7. Nutritional Support:
    • Omega-3 Fatty Acids: Found in fish oil or flaxseed oil, these have anti-inflammatory effects that may help alleviate depression.
    • Vitamin B12: Essential for serotonin production; deficiencies are often linked to depressive symptoms.

Testing for Micronutrients and HPA Axis Imbalances

For a personalized approach, clinicians can use:

  • Essential Nutrient Testing: Identifies imbalances in micronutrients
  • Salivary Cortisol and Melatonin Testing: Highlights diurnal rhythm disruptions, offering insights into the HPA axis and circadian dysfunction.

By identifying specific biochemical imbalances, clinicians can tailor interventions with greater accuracy, enhancing patient outcomes. Integrating lab testing into practice not only improves care but is essential in personalized medicine.

 

Supporting patients with SAD through functional approaches empowers them to navigate seasonal transitions more effectively. However, if left unaddressed, this condition will likely recur annually, creating a persistent cycle of symptoms that can significantly impact quality of life. By addressing underlying physiological imbalances and implementing targeted interventions, we can offer holistic and sustainable relief to those affected by this condition.

 

Make an appointment today to find out more about how our Denver functional medicine office can help.